Document is current
Any future updates will be listed below
-
Authors
Alizadeh, Madeline
Cross, Raymond K.
Cohen, Erica
- License Information
-
More Information
Article History
Received: 24 April 2025
Accepted: 11 June 2025
First Online: 12 July 2025
Declarations
:
: ERC has the following disclosures: Speaker Bureau: Abbvie, Janssen, Takeda, Eli Lily. Consultant: Abbive, Janssen, Takeda, Eli Lily, Pfizer. RKC has the following disclosures: Advisory Board/Consulting: Abbvie, Bristol-Myers Squibb, Genentech; Magellan Health, Option Care, Pfizer, Pharmacosmos, Samsung Bioepis, and Sandoz. Speaker’s Bureau: Abbvie, Bristol-Myers Squibb, Janssen, and Pfizer. Executive Committee Member: IBD Education Group. Scientific Co-Director: CorEvitas Registry. DSMB: Gilead. Research Grants: Janssen and Takeda.
